Pó de esteróides da China / GBL / Peptídeos / HGH
bucky@pharm-chemicals. com +8613237122310
EnglishFrançaisDeutschLatīnaپارسیPortuguêsРусскийEspañolSvenskaTürkçe
 Editar tradução

Peptídeos

» Peptídeos

Lanreotide CAS:108736-35-2

Lanreotide
CAS No.:108736-35-2
MF: C54H69N11O10S2
MW: 1096.32
Ensaio:98%
Aparência:white to off-white lyophilised powder

investigação
  • Especificações

Lanreotide is a synthetic analogue of somatostatin, a naturally occurring inhibitory hormone which blocks the release of several other hormones, including growth hormone, thyroid-stimulating hormone (TSH), insulin and glucagon.

Lanreotide binds to the same receptors as somatostatin, although with higher affinity to peripheral receptors, and has similar activity. No entanto, while somatostatin is quickly broken down in the body (within minutes), lanreotide has a much longer half-life, and produces far more prolonged effects.The efficacy of lanreotide has not been extensively studied, and results differ greatly between trials and formulations.

Lanreotide (POUSADA) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. Its sequence is H-D-2Nal-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Thr-NH2.

Lanreotide (as lanreotide acetate) is manufactured by Ipsen, and marketed under the trade name Somatuline. It is available in several countries, including the United Kingdom, Australia and Canada, and was approved for sale in the United States by the Food and Drug Administration (FDA) on August 30, 2007.

Product Applications:

Lanreotide is used in the treatment of acromegaly, due to both pituitary and non-pituitary growth hormone-secreting tumors, and the management of symptoms caused by neuroendocrine tumors, particularly carcinoid tumors and VIPomas. In the United States and Canada, lanreotide is only indicated for the treatment of acromegaly.

In the United Kingdom, it is also indicated in the treatment of thyrotrophic adenoma, a rare tumor of the pituitary gland which secretes.

Lanreotide also shows activity against non-endocrine tumors, e, along with other somatostatin analogues, is being studied as a possible general antitumor agent.

Lanreotide ,The main side effects of lanreotide treatment are mild to moderate pain at the injection site and gastrointestinal disturbances, such as diarrhea, nausea and vomiting. Isolated cases of gallstone formation have been associated with use of lanreotide, particularly over long periods of time.

CATEGORIA E ETIQUETAS:
Peptídeos , , , , , , , , , , , , , , , , , , ,

Formulário de consulta ( nós te retornaremos o mais rápido possível )

Nome:
*
E-mail:
*
Mensagem:

Verificação:
1 + 3 = ?

Talvez você goste também

  • Nossa vantagem

    Alta qualidade

    Bom preço

    Garantia de entrega

    Melhor serviço

    100% Dinheiro de volta

  • Produtos Principais

    GBL

    BDO

    Trembolona A/E

    Testosterona E/P

    HGH/HCG/IGF

  • Termos de pagamento

    Bitcoin

    Transferência bancária

    Western Union

    Grama de dinheiro

  • Contate-nos

    E-mail: bucky@pharm-chemicals. com

    Whatsapp: +8613237122310

    www.china-steroids-powder.com